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Abstract
Background: Different microarray data sets can be collected for studying the same or similar
diseases. We expect to achieve a more efficient analysis of differential expression if an efficient
statistical method can be developed for integrating different microarray data sets. Although many
statistical methods have been proposed for data integration, the genome-wide concordance of
different data sets has not been well considered in the analysis.
Results:  Before considering data integration, it is necessary to evaluate the genome-wide
concordance so that misleading results can be avoided. Based on the test results, different
subsequent actions are suggested. The evaluation of genome-wide concordance and the data
integration can be achieved based on the normal distribution based mixture models.
Conclusion:  The results from our simulation study suggest that misleading results can be
generated if the genome-wide concordance issue is not appropriately considered. Our method
provides a rigorous parametric solution. The results also show that our method is robust to certain
model misspecification and is practically useful for the integrative analysis of differential expression.
Background
Microarray is an experimental method by which tens of
thousands of genes can be printed on a small chip and
their expression can be measured simultaneously [1,2].
Since the microarray technology was introduced, it has
been widely used in many biomedical studies [3,4].
Microarrays can be used to measure expression for tens of
thousands of genes at the mRNA level for samples in nor-
mal and disease groups, and then statistical methods for
two-sample comparison can be used to identify differen-
tially expressed genes. Differentially expressed genes are
potential disease related genes for clinical diagnoses and
medical treatments. This approach has been successfully
used in cancer studies [4,5] as well as diabetes studies
[6,7].
Although microarray technology has been developed for
more than a decade, the experiment cost is still consider-
ably expensive. This limits the sample size of microarray
studies. Therefore, the detection power can be low, espe-
from The Seventh Asia Pacific Bioinformatics Conference (APBC 2009)
Beijing, China. 13–16 January 2009
Published: 30 January 2009
BMC Bioinformatics 2009, 10(Suppl 1):S23 doi:10.1186/1471-2105-10-S1-S23
<supplement> <title> <p>Selected papers from the Seventh Asia-Pacific Bioinformatics Conference (APBC 2009)</p> </title> <editor>Michael Q Zhang, Michael S Waterman and Xuegong Zhang</editor> <note>Research</note> </supplement>
This article is available from: http://www.biomedcentral.com/1471-2105/10/S1/S23
© 2009 Lai et al; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Bioinformatics 2009, 10(Suppl 1):S23 http://www.biomedcentral.com/1471-2105/10/S1/S23
Page 2 of 11
(page number not for citation purposes)
cially when the signal of differential expression is rela-
tively weak [8]. Many microarray data sets have been
collected for the same or similar research purpose. Detect-
ing genes with concordant behavior among different data
sets is of biological interest. It is also of statistical interest
to improve the detection power if it is feasible to integrate
different data sets in differential expression analysis. For
this reason, several methods have been proposed for data
integration [9-14].
However, the genome-wide concordance of different data
sets has not been well considered in these integrative anal-
yses. A gene selected for the follow-up analysis should
behave concordantly in different data sets. For example, if
a gene is up-regulated in one experiment, then it should
also be up-regulated in another experiment. Slight incon-
sistency should be expected since there are considerable
noises generated by microarray experiments. If two data
sets are genome-wide concordant, then integrating them
can generally improve the sample size and reduce the
noise impact. Therefore, it is desirable to combine obser-
vations of concordant genes since we expect to achieve a
more powerful detection of differential expression. How-
ever, if two data sets are not genome-wide concordant,
then there are genes with discordant behavior in different
data sets. There are many possible factors for such obser-
vations, such as population heterogeneity, probe binding
issues from different microarray platforms, as well as lab-
specific system noises. Therefore, integrating observations
of discordant genes may result in misleading conclusions
and should be discouraged.
When a seemingly discordant behavior is observed for a
gene, it is difficult to tell whether the observation is gener-
ated by random noises or the observation reflects the
underlying truth. Therefore, it is not trivial to determine
whether a gene has a concordant/discordant behavior in
different experiments. The analysis will be more compli-
cated for evaluating genome-wide concordance. Cahan et
al. [15] have studied different gene lists identified from
different data sets. Ein-Dor et al. [16] have showed that we
may need to collect thousands of samples to generate a
robust gene list for disease prediction. Miron et al. [17]
have proposed a correlation based approach for measur-
ing concordance between two lists of test statistics from
two data sets. However, this approach does not consider
the fact that different genes in a data set belong to differ-
ent components (non-differentially expressed, up-regu-
lated, down-regulated, etc.). We have recently proposed a
mixture-model based method for testing genome-wide
concordance and discordance [18]. This approach consid-
ers the mixture of different gene components as well as the
independence between two data sets, and it can be
extended for data integration. In this study, we propose a
mixture-model based statistical framework to achieve a
rigorous integrative analysis of differential expression.
In a recent study [19], it has been shown that the widely
used overlap count (or Venn diagrams) is not an appropri-
ate metric for measuring the reproducibility of differential
expression analysis. It is necessary to develop new metrics
for rigorously measuring the reproducibility of differen-
tial expression analysis. The disadvantage of overlap
count metric is that the randomness of differential expres-
sion measures (e.g. t-test) has not been well considered.
However, our mixture-model based tests of genome-wide
concordance and discordance [18] take this randomness
into account and the reported p-values can be used as rig-
orous metrics for measuring the reproducibility of differ-
ential expression analysis.
For the rest of paper, we first introduce our statistical
framework. Then, we use simulated data to evaluate its
performance. Two experimental data based case studies
are considered as the applications. Finally, we discuss the
advantages and disadvantages of our method.
Methods
A statistical framework
Figure 1 provides an illustrative flow chat for our statisti-
cal framework. The integration of two microarray gene
expression data sets is considered so that we can achieve a
more powerful detection of concordantly differentially
expressed genes. Here, we assume that two data sets have
been pre-processed so that they contain the same gene list.
The framework can be summarized as the procedure
below. Then, we describe the detail of each step. (See our
recent publication [18] for the technical detail of tests of
complete concordance and complete discordance.)
1. In each data set, perform a statistical test of differential
expression for each gene to obtain a lists of test scores;
2. For each list of test scores, perform a transformation
procedure to obtain a list of z-scores;
3. For two lists of z-scores, test the complete discordance
between them;
(a) if the complete discordance cannot be rejected, then
the data integration will be discouraged;
(b) if the complete discordance can be rejected, then con-
tinue to the next step;
4. For two lists of z-scores, test the complete concordance
between them;BMC Bioinformatics 2009, 10(Suppl 1):S23 http://www.biomedcentral.com/1471-2105/10/S1/S23
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(a) if the complete concordance cannot be rejected, then
calculate a list of concordant integrative scores based on
the complete concordance (CC) model;
(b) if the complete concordance can be rejected, then cal-
culate a list of concordant integrative scores based on the
partial concordance/discordance (PCD) model;
5. Use the list of concordant integrative scores to prioritize
genes for the follow-up study.
Test of differential expression
For simplicity, we consider the Student's two-sample t-test
for differential expression analysis. Other test statistics,
such as Wilcoxon's rank sum test or a generalized t/F-sta-
tistic [20], can certainly be considered. The statistical sig-
nificance (p-value) of a test value can be evaluated based
on either its theoretical null distribution or a permutation
null distribution [21]. In this study, the theoretical p-value
is used for the simulation study since we know the under-
lying distribution; the permutation p-value is used for the
application since the underlying distribution is unknown
(B = 500 is used as the number of permutations).
Transformation of test score
It has been suggested transforming a test value to its asso-
ciated z-score so that more efficient results can be achieved
in a normal mixture model based analysis [22]. When the
one-sided (upper-tailed) p-value of a test value is availa-
ble, the associated z-score can be simply calculated by
z = Φ-1(1 - p),
where Φ-1(·) is the inverse of standard normal distribu-
tion. Notice that it is necessary to use one-sided p-values
Flow chart Figure 1
Flow chart. A flow chart illustrates our statistical framework. The details are provided in the Methods section.
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since we intend to distinguish up-regulated differential
expression from down-regulated differential expression.
Mixture models
We have proposed several mixture models [18] to evalu-
ate the genome-wide concordance/discordance between
two lists of z-scores: {(z1k, z2k) : k = 1, 2, ..., m}, where m is
the number of common genes in both data sets. A general
mixture model can be used to represent the case of partial
concordance/discordance (PCD):
This model can be reduced to a complete concordance
(CC) model:
and a complete discordance (CD) model:
More details for these models have been described in our
recent publication [18]. In these models, index 0 is used
to represent the null component with fixed parameters: μ0
= ν0 = 0 and  ; indices 1 and 2 are used to rep-
resent the down-regulated and up-regulated components
with constrains: μ1, ν1 ≤ 0 and μ2, ν2 ≥ 0; πij is the propor-
tion of genes belonging to the i-th component in the first
data set and j-th component in the second data set (Σij πij
= 1). πi. is the marginal proportion of genes belonging to
the i-th component in the first data set; and π.j is the mar-
ginal proportion of genes belonging to the j-th compo-
nent in the second data set. The model parameters can be
estimated through an E-M algorithm [23]. The detail has
also been described in our recent publication [18].
Tests of concordance and discordance
Based on the assumption of independence among the list
of z-scores, we can calculate the mixture model based like-
lihoods:
With these likelihoods, we can test PCD (H1) against CC
(H0) or CD (H0) by the following likelihood ratio tests in
the logarithm scale:
The statistical significance of a test value can be evaluated
by the parametric bootstrap procedure [24], which has
also been described in our recent publication [18].
Data integration
If the complete discordance (CD) cannot be rejected, then
the data integration will be discouraged to avoid mislead-
ing results. If CD can be rejected, then either the complete
concordance (CC) or the partial concordance/discordance
(PCD) will be established. Although CC is a special case
of PCD, it is still statistically necessary to test PCD against
CC. If CC cannot be rejected, then we expect to achieve a
more efficient data integration by reducing the number of
parameters. Under CC or PCD, it is feasible to consider
the data integration. To prioritizing genes, we can con-
sider a concordant integrative score, which is the condi-
tional probability of concordantly differential expression
under an appropriate mixture model: [P(observed pair of
z-scores both up-regulated) + P(observed pair of z-scores
both down-regulated)]/P(observed pair of z-scores).
Under the CC model, it is calculated as:
Under the PCD model, it is calculated as:
False positive control
The mixture model provides a rigorous convenience to
estimate the number of false positives in a theoretical
manner. Notice that the above concordant integrative
score is actually a probability of true positive. Therefore, if
we are interested in the top K genes {X(1), X(2), ..., X(K)}
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ranked by the concordant integrative score, then the asso-
ciated number of false positives can be estimated as:
where S(·) is calculated based on an appropriate mixture
model (CC or PCD). With this estimate, one may realize
that the false discovery rate [25] (FDR) based on the q-
value concept [26] can be simply estimated as  /K.
For an individual data set, we simply use the R-package
qvalue  [26] to obtain the estimated FDR. Then, the
number of false positives for the top K genes can be simple
estimated as K × FDR(K), which is theoretically consistent
with the above  .
Results and discussion
Illustrative examples
Figure 2 shows three examples to illustrate the concepts of
concordance and discordance. These examples are simu-
lated based on the simulation configuration in the next
subsection. The proportions of genes with discordant
behavior in two data sets are ξ = 0%, 50% and 100%,
respectively. Therefore, these are representative examples
for the cases of complete concordance, partial concord-
ance/discordance and complete discordance. The corre-
sponding Pearson's correlation coefficients are 49.2%,
36.1% and -2.1%. Therefore, the correlation measure is
not an appropriate metric to tell whether two data sets are
concordant or not. One may also realize that the overlap
count is neither a rigorous approach even for the first 
example (a case of complete concordance).
A simulation study
There are many parameters to be considered when we
simulate microarray gene expression data:
￿ Gene size m;
￿ The proportion of non-differentially expressed genes π0;
￿ Sample sizes of two groups n1, n2;
￿ Distributions of expression measurements of differen-
tially and non-differentially expressed genes;
￿ Covariance structure among genes.
In our simulation studies, we consider the widely used
block structure: genes are partitioned into many blocks;
genes within the same block are positively dependent; and
different blocks are independent. To save the computing
time, we reasonably set gene size m = 6000, π0 = 80% and
n1 = n2 = 15 for each of two data sets. The block size
(number of genes in each block) is set b = 25. Within each
block, the expression measurements are simulated from a
multivariate normal distribution. For blocks of non-dif-
ferentially expressed genes, we simulate expression meas-
urements from N(,   Σ0), where   is a b × 1 vector of
0's and Σ0 is a b × b matrix with diagonal entries as 1 and
non-diagonal entries as a fixed value (simulated from a 
FP K S z z kk
k
K
m =−
= ∑ (,) , ,( ) ,( ) 12
1
FP m
FP m
ˆ μ0 ˆ μ0
Illustrative examples Figure 2
Illustrative examples. Three examples demonstrate the concepts of genome-wide concordance and discordance. The up-
triangles, down-triangles and circles represent the concordantly up-regulated, down-regulated and null genes; the diamonds 
represent the discordantly expressed genes.
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Uniform distribution U[0.5, 0.9]). For blocks of differen-
tially expressed genes, we simulate expression measure-
ments from N(,   Σ1) and N(,   Σ2) for the first and the
second sample groups, respectively.   is simply a b × 1
vector of 0's. To simulate  , we first simulate b × 1 vector
of random numbers from a Beta distribution Beta(1.5,
1.5), multiply this vector by a factor r = 1.5, and then mul-
tiply randomly simulated signs (50% positive and 50%
negative) so that both up and down regulated differential
expression can be generated. Σ1 and Σ2 are similarly gener-
ated as Σ0. Two data sets are first simulated based on the
same configuration. To simulate genes with discordant
behavior, we randomly reallocate ξ  = 0%, 15%, 30%,
45%, 60% and 75% genes in the second data set so that
these genes are no longer matched with those in the first
data set. Notice that the simulation configuration is not
completely consistent with what have been assumed for
our method. This is intentionally designed to understand
the robustness of our method. The complete concordance
or the complete discordant will be rejected at the level p-
value < 0.025 since there is a issue of multiple hypothesis
testing. To save computing time, we only perform the par-
ametric bootstrap for 100 times to evaluate the p-value of
a test.
For each round of simulation, since we know the truth
(simulation configuration), we can use the curve of
number of concordantly differentially expressed genes
(True Positives) against number of claimed ones
(Claimed Positives) to evaluate the performance of our
method. After many (50) rounds of simulations (it takes
a long time for each round due to the parametric boot-
strap procedure with the E-M algorithm based estima-
tion), we can take the average to obtain a smooth mean
curve. Since the existing data integration methods [9-14]
ˆ μ1 ˆ μ2
ˆ μ2
ˆ μ1
Simulation results Figure 3
Simulation results. The curves of number of truly concordantly differentially expressed genes (True Positives) against 
number of claimed ones (Claimed Positives) are used to evaluate the performance of our method. Different proportions of dis-
cordant genes (0 ~ 75%) are considered. The solid curves represent our mixture-model based approach; the dotted curves 
represent the pooling approach for a comparison.
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do not consider the issue of genome-wide concordance/
discordance, they are not included for comparison in this
study. However, we have compared our method with the
simple pooling approach: observations of the same gene
from two data sets are simply combined for each sample
group, and the t-test is applied to each gene in the pooled
data set. This approach is feasible since the measurements
in two simulated data sets are comparable. (Then, this
approach is a desired efficient approach when two data
sets are genome-wide concordant. It is interesting to
understand its loss of power when two sets are not
genome-wide concordant.)
Figure 3 shows the comparison between our method and
the pooling approach. When ξ = 0% (complete concord-
ance), the performance of two approaches are still compa-
rable. (Notice that in such a situation, the pooling
approach is an ideal choice.) Our tests of complete con-
cordance (CC) and complete discordance (CD) result in
45 CC and 5 partial concordance/discordance (PCD)
among 50 repetitions. The advantage of our method
becomes clearer and clearer when ξ is increased from 15%
to 75% (partial concordance/discordance): our method is
clearly better when the number of claimed positives is
within 1 to 1000 (notice that relatively lowly ranked genes
are of less interest in microarray studies). Our tests of CC
and CD result in 50 PCD among 50 repetitions for all
these 5 configurations. In addition to the practical useful-
ness of our method, Figure 3 also confirms that it is
importance to evaluate the genome-wide concordance
before the data integration can be considered. Otherwise,
we may obtain seriously misleading analysis results.
Applications
A case study of partial concordance/discordance
Since NOD mouse spontaneously develops type 1 diabe-
tes, it has been widely used for studying the disease. Based
on a time course microarray study using samples collected
Application results Figure 4
Application results. Two scatter-plots show the paired p-values (a) and the paired z-scores (b) from two NOD mouse data 
sets. The false discovery rate curves (c) compare the results based on the PCD model based data integration, the CC model 
based data integration and two individual sets. The gene ranks based on the PCD model based integration and two individual 
data sets are also compared (d-f).
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from 3 weeks to 10 weeks, week 5 is a key checkpoint for
the development of type 1 diabetes [7]. To distinguish the
genes related to diabetes development from the genes
related to aging, two other data sets have also been col-
lected for two congenic strains: NOD.Idd3/Idd10 and
NOD.B10Sn-H2, which do not spontaneously develop
diabetes. Samples have been collected at different time
points from 3 weeks to 10 weeks [7]. Although these two
strains do not spontaneously develop type 1 diabetes, it is
still interesting to understand their differential expression
before 5 weeks vs. after 5 weeks. Furthermore, under-
standing genes with concordant/discordant behavior for
these two strains is important. Therefore, the data set col-
lected for each congenic strain is partitioned into two
sample groups: for strain NOD.Idd3/Idd10, there are 11
and 13 subjects collected before 5 weeks and after 5
weeks, respectively; for strain NOD.B10Sn-H2, there are
22 and 10 subjects collected before 5 weeks and after 5
weeks, respectively. Measurements for 11,424 genes have
been collected based on a cDNA microarray platform.
Figures 4a and 4b show the scatter-plot for the paired p-
values (based on 500 permutations) and z-scores of
11,424 genes based on these two data sets. It is difficult to
evaluate the genome-wide concordance/discordance
based on the scatter-plot of paired p-values (Figure 4a).
From the scatter-plot of paired z-scores (Figure 4b), the
genome-wide concordance seems quite satisfactory. How-
ever, based on 1000 parametric bootstraps (Table 1), the
tests of complete concordance (CC) and complete dis-
cordance (CD) are both significant (p < 0.01). Therefore,
both CC and CD models are rejected and the partial con-
cordance model (PCD) should be used in the analysis.
This is not surprising since certain genetic and biological
differences are expected from these two similar strains.
Table 2 gives the PCD model estimates. There are still
about 75% genes with concordant behavior. The level of
darkness in Figure 4b represents the level of being con-
cordantly differentially expressed that is evaluated by the
concordant integrative score based on the PCD model (we
set 0.2 for the smallest darkness level so that these non-
differentially expressed genes can be visualized).
Figure 4c shows the estimated false discovery rates. Com-
pared to the analysis based on individual data sets, the
PCD model based false positive control is not necessarily
better since we intend to detect these concordantly differ-
entially expressed genes in the integrative data analysis.
Furthermore, it is important that an appropriate model
must be used for the data integration. Figure 4c also shows
that the CC model based analysis results can be seriously
misleading. Therefore, the tests of complete concordance
and complete discordance are crucial before the data inte-
gration can be considered. Figure 4d–f compare the gene
ranks based on the PCD model based integration and two
individual data sets. The gene ranks based on two individ-
ual data sets are quite discordant: the Spearman's rank
correlation is just 0.36. The integration based gene ranks
and these based on two individual data sets are quite con-
cordant: the Spearman's rank correlations are 0.78 and
0.72, respectively.
A case study of complete concordance
In practice, we may collect gene expression data for the
same study from different laboratories based on different
microarray platforms. These data usually cannot be
Table 2: Application results. The parameters in the PCD model for two NOD mouse data sets are estimated through an E-M 
algorithm.
Data Set Two (NOD.B10Sn-H2)
Down Null Up Mean Variance
Data Set One Down 0.150 0.078 0.001 -2.424 1.279
Null 0.076 0.488 0.018 0 1
(NOD.Idd3/Idd10) Up 0.002 0.079 0.109 2.685 1.493
Mean -2.032 0 3.209
Variance 1.333 1 0.777
Table 1: Application results. The parametric bootstrap based null quantiles are used to evaluate the significance (p-values) of the tests 
of complete discordance and complete concordance between two NOD mouse data sets.
Quantile under Null
Test Observed 90% 95% 99% 99.5% 99.9%
Complete Discordance (TCD) 2477.1 2.6 3.2 4.6 5.5 7.3
Complete Concordance (TCC) -269.3 -378.9 -371.6 -350.9 -345.8 -340.5BMC Bioinformatics 2009, 10(Suppl 1):S23 http://www.biomedcentral.com/1471-2105/10/S1/S23
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directly combined for an analysis with a larger sample
size. Our method can also be used to solve this problem.
Although this situation has been discussed in our simula-
tion study, it is still necessary to illustrate it with experi-
mental data. Here, we generate a case of complete
concordance based on an experimental data set. The data
set was collected for a prostate cancer study [5]. Genome-
wide expression profiles for 6034 genes (after data pre-
processing) have been measured for 50 normal and 52
cancerous subjects. We randomly split this data set into
two subsets with equal sample sizes (25 normal and 26
cancerous subjects).
Figures 5a and 5b show the scatter-plot for the paired p-
values (based on 500 permutations) and z-scores of 6,034
genes based on these two subsets. They are highly
genome-wide concordant. This is consistent with our
expectation. Based on 1000 parametric bootstraps (Table
3), the complete discordance is rejected (p < 0.01) but the
complete concordance cannot be rejected (the associated
p-value is highly insignificant). Table 4 gives the CC
model estimates. The estimates of mean and variance
parameters in two subsets are consistent. The level of dark-
ness in Figure 5b represents the level of being concord-
antly differentially expressed that is evaluated by the
concordant integrative score based on the CC model (0.2
is set for the smallest darkness level so that these non-dif-
ferentially expressed genes can be visualized).
Figure 5c shows the estimated false discovery rates. Com-
pared to the analysis based on individual data sets, the CC
model based false positive control shows a clear improve-
Application results Figure 5
Application results. Two scatter-plots show the paired p-values (a) and the paired z-scores (b) from two prostate cancer 
data subsets. The false discovery rate curves (c) compare the results based on the CC model based data integration, the origi-
nal data (subsets 1 and 2 pooled together) and two individual subsets. The gene ranks based on the CC model based integra-
tion and two individual subsets are also compared (d-f).
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Table 3: Application results. The parametric bootstrap based null quantiles are used to evaluate the significance (p-values) of the tests 
of complete discordance and complete concordance between two NOD mouse data sets.
Quantile under Null
Test Observed 90% 95% 99% 99.5% 99.9%
Complete Discordance (TCD) 1515.8 1.1 1.4 2.4 2.6 3.2
Complete Concordance (TCC) -635.4 -264.4 -257.2 -245.7 -241.8 -234.9BMC Bioinformatics 2009, 10(Suppl 1):S23 http://www.biomedcentral.com/1471-2105/10/S1/S23
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ment. However, the false positive control based on the
original data (subsets 1 and 2 pooled together) is the best.
This is consistent with our simulation results. Figure 5d–f
compare the gene ranks based on the CC model based
integration and two individual subsets. The gene ranks
based on two individual subsets are quite discordant: the
Spearman's rank correlation is just 0.50. The integration
based gene ranks and these based on two individual data
sets are quite concordant: the Spearman's rank correla-
tions are both 0.81. Furthermore, the integration based
gene ranks are highly concordant with these based on the
original data (result not shown): the Spearman's rank cor-
relation is 0.96.
Conclusion
In this study, we have proposed a statistical framework for
integrating two microarray gene expression data sets in
differential expression analysis. Our simulation and
application results confirm that it is necessary to evaluate
the genome-wide concordance before the consideration
of data integration. Otherwise, misleading results can be
generated from the integrative analysis. Our current study
focuses on the integration of two data sets with two-sam-
ple groups. In our future study, we will generalize our
method for multiple data sets. However, it is less straight-
forward to generalize our method for multi-sample
groups since it is difficult to define the concordance/dis-
cordance for multiple groups.
Because of the randomness of data, we can always observe
some intersection of genes selected from two data sets if
the selection criterion is not stringent. This is the case even
when two data sets are completed unrelated. (If the selec-
tion criterion is stringent, then we may always observe a
null intersection even when two data sets are actually
related.) Therefore, the genome-wide concordance/dis-
cordance is a critical issue in the integrative analysis
microarray data. The traditional hyper-geometric analysis
relies on the criterion of gene selection, which can be
quite arbitrary in practice. For example, the results based
on the threshold of 5%, 10% or 20% false discovery rates
can be considerably different. It is not a rigorous approach
to address the genome-wide concordance/discordance. In
a recent study [19], it has also been shown that the widely
used overlap count (or Venn diagrams) is not an appropri-
ate metric for measuring the reproducibility of differential
expression analysis. Furthermore, it is not clear how to
rank genes efficiently in the intersection of genes selected
from two data sets.
To our knowledge, there is no other existing methods for
evaluating genome-wide concordance/discordance before
the consideration of data integration. Our mixture model
based approach is simple and intuitive. There are usually
3 major gene groups in a data set: up-regulated, down-reg-
ulated and null genes, which correspond to the three com-
ponents in our model. The model inference is well-
developed in the field of statistics. Furthermore, our
model allows us to provide rigorous ranks for genes ana-
lyzed in two data sets. In our simulation study, our
method can still provide a comparable performance in the
situation of complete genome-wide concordance when
the ideal pooling approach is feasible. If two data sets are
not completely concordant, then our method will provide
a better performance.
Our method has several advantages. It allows us to test
genome-wide concordance/discordance, which is a criti-
cal issue before the data integration can be considered. It
is a likelihood-based approach, which is efficient when
the underlying model is not seriously mis-specified. We
have also showed the robustness of our method through
a simulation study when the underlying models are some-
what inconsistent. Furthermore, the data integration is
achieved through a rigorously defined probability with
close formulas.
Our method also has the following disadvantages. It is dif-
ficult to validate the assumed mixture model. However,
without this assumption, we currently have no effect
approach for evaluating genome-wide concordance/dis-
cordance. Furthermore, the calculation of likelihood
assumes that the test scores from different genes are inde-
pendent. However, it is well-known that the covariance
structure of a microarray gene expression data set can be
complicated. In our future study, we will explore more
efficient approaches to overcome these disadvantages.
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